TGF beta 1 Protein, Human, Recombinant

1/2
Price:
Size:
Number:

TGF beta 1 Protein, Human, Recombinant: Product Information

Purity
> 95 % as determined by HPLC.
Endotoxin
< 1.0 EU per μg of the protein as determined by the LAL method
Activity
Measured by its ability to inhibit cell proliferation of Mv-1-lu mink lung epithelial cells.
The ED50 for this effect is typically 0.04-0.2 ng/mL.
Protein Construction
A DNA sequence encoding the active form of human/rhesus/canine TGFβ1 (NP_000651.3) (Ala 279-Ser 390) was expressed and purified. Human, Rhesus and Canine TGFβ1 sequences are identical.
Accession#
Expressed Host
CHO Stable Cells
Species
Human
Predicted N Terminal
Ala 279
Molecule Mass
The recombinant human/rhesus/canine TGFβ1 consists of 112 amino acids and has a calculated molecular mass of 12.8 kDa. it migrates as an approximately 13 & 26 kDa band in reduced and non-reduced SDS-PAGE respectively, corresponding to the monomer and homodimer.
Formulation
Lyophilized from sterile 100mM GLY, 10mM NaCl, pH 3.0
1. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
2. Please contact us for any concerns or special requirements.
Please refer to the specific buffer information in the hard copy of CoA.
Shipping
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.
Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Stability & Storage
Samples are stable for up to twelve months from date of receipt at -70℃
Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution
A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

TGF beta 1 Protein, Human, Recombinant: Images

TGF beta 1 Protein, Human, Recombinant: Alternative Names

CED Protein, Human; DPD1 Protein, Human; LAP Protein, Human; TGF-beta 1 Protein, Human; TGFB Protein, Human; TGFbeta Protein, Human

TGF beta 1 Background Information

TGF-beta 1 is a member of the transforming growth factor beta (TGF-beta) family. The transforming growth factor-beta family of polypeptides are involved in the regulation of cellular processes, including cell division, differentiation, motility, adhesion and death. TGF-beta 1 positively and negatively regulates many other growth factors. It inhibits the secretion and activity of many other cytokines including interferon-γ, tumor necrosis factor-alpha and various interleukins. It can also decrease the expression levels of cytokine receptors. Meanwhile, TGF-beta 1 also increases the expression of certain cytokines in T cells and promotes their proliferation, particularly if the cells are immature. TGF-beta 1 also inhibits proliferation and stimulates apoptosis of B cells, and plays a role in controlling the expression of antibody, transferrin and MHC class II proteins on immature and mature B cells. As for myeloid cells, TGF-beta 1can inhibit their proliferation and prevent their production of reactive oxygen and nitrogen intermediates. However, as with other cell types, TGF-beta 1 also has the opposite effect on cells of myeloid origin. TGF-beta 1 is a multifunctional protein that controls proliferation, differentiation and other functions in many cell types. It plays an important role in bone remodeling as it is a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts. Once cells lose their sensitivity to TGF-beta1-mediated growth inhibition, autocrine TGF-beta signaling can promote tumorigenesis. Elevated levels of TGF-beta1 are often observed in advanced carcinomas, and have been correlated with increased tumor invasiveness and disease progression.
Full Name
transforming growth factor, beta 1
Research Areas
References
  • Ghadami M, et al. (2000) Genetic Mapping of the Camurati-Engelmann Disease Locus to Chromosome 19q13.1-q13.3. Am J Hum. Genet. 66(1):143-7.
  • Letterio J, et al. (1998) Regulation of immune responses by TGF-beta. Annu Rev Immunol. 16:137-61.
  • Vaughn SP, et al. (2000) Confirmation of the mapping of the Camurati-Englemann locus to 19q13. 2 and refinement to a 3.2-cM region. Genomics. 66(1):119-21.
  • Assoian R, et al. (1983) Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem. 258(11):7155-60.
  • Lyso-globotriaosylceramide downregulates KCa3.1 channel expression to inhibit collagen synthesis in fibroblasts
    Author
    Choi, JY;Shin, MY;Suh, SH;Park, S;
    Year
    2015
    Journal
    Biochem. Biophys. Res. Commun.
    Application
    cell-based
  • Overexpression of SerpinE2/protease nexin-1 Contribute to Pathological Cardiac Fibrosis via increasing Collagen Deposition
    Author
    Li, X;Zhao, D;Guo, Z;Li, T;Qili, M;Xu, B;Qian, M;Liang, H;E, X;Chege Gitau, S;Wang, L;Huangfu, L;Wu, Q;Xu, C;Shan, H;
    Year
    2016
    Journal
    Sci Rep
    Application
    culture
  • Neonatal rat fibroblast isolation, culture, differentiation and determination of microRNA effects in transformation
    Author
    Tao, L;Wang, H;Yang, X;
    Year
    2017
    Journal
    Non-coding RNA Investigation
    Application
    cell-based (differentiation)
  • OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ
    Author
    Zhang, Z;Du, J;Wang, S;Shao, L;Jin, K;Li, F;Wei, B;Ding, W;Fu, P;van Dam, H;Wang, A;Jin, J;Ding, C;Yang, B;Zheng, M;Feng, XH;Guan, KL;Zhang, L;
    Year
    2018
    Journal
    Mol. Cell
  • ROCK Inhibitor Y27632 Induced Morphological Shift and Enhanced Neurite Outgrowth-Promoting Property of Olfactory Ensheathing Cells via YAP-Dependent Up-Regulation of L1-CAM
    Author
    Li, Y;Huo, S;Fang, Y;Zou, T;Gu, X;Tao, Q;Xu, H;
    Year
    2018
    Journal
    Front. Cell. Neurosci.
  • Sphingomyelin synthase 1 regulates the epithelial‑to‑mesenchymal transition mediated by the TGF‑β/Smad pathway in MDA‑MB‑231 cells
    Author
    Liu, S;Hou, H;Zhang, P;Wu, Y;He, X;Li, H;Yan, N;
    Year
    2018
    Journal
    Mol Med Rep
    Application
    cell-based
  • Alogliptin alleviates liver fibrosis via suppression of activated hepatic stellate cell
    Author
    Zhang, H;Sun, D;Wang, G;Cui, S;Field, RA;Li, J;Zang, Y;
    Year
    2019
    Journal
    Biochem. Biophys. Res. Commun.
    Application
    cell-based
Add to Cart Successfully Add to Cart Failed Shopping cart is being updated, please wait